Loading…

First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients

Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collec...

Full description

Saved in:
Bibliographic Details
Published in:BMC infectious diseases 2024-01, Vol.24 (1), p.151-12, Article 151
Main Authors: Donida, Bianca Maria, Pirola, Flavia Simonetta, Opizzi, Roberto, Assembergs, Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183
container_end_page 12
container_issue 1
container_start_page 151
container_title BMC infectious diseases
container_volume 24
creator Donida, Bianca Maria
Pirola, Flavia Simonetta
Opizzi, Roberto
Assembergs, Peter
description Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020. A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases. In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.
doi_str_mv 10.1186/s12879-024-09034-4
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_98af8fd200f645158b2038ad96742d92</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A782197899</galeid><doaj_id>oai_doaj_org_article_98af8fd200f645158b2038ad96742d92</doaj_id><sourcerecordid>A782197899</sourcerecordid><originalsourceid>FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</originalsourceid><addsrcrecordid>eNqNkttu1DAQhiMEoqXwAlwgS9yA1BSfkti9QWWhsFKllTj01vL6kHWVxMH2LpSH4VlxdkvpIi5QFNmefPNPZvwXxVMETxBi9auIMGt4CTEtIYeElvRecYhog0pMCL1_Z39QPIrxCkLUMMwfFgckLw3G9LD4ee5CTGC2uJy_LREH3-TGADeAtDJgDH7jBmWAt-CNCa3s_TGYJ9ldnwIzOm165zvfOiU7IAcNVOeG7UGtZJAqmeBicioeA79OyvdmS_VykK3pzZAm3amO3f7CysfRZXH3w2gwyuQyER8XD6zsonlysx4VX87ffZ59KC8W7-ezs4tSVYykUslKVtxqYlWlamKXsmqwVbpmhlptl_mtK8qMoZohw5YYk1opgnIGVhQxclTMd7rayysxBtfLcC28dGIb8KEVMuReOiM4k5ZZjSG0Na1QldUgYVLzuqFYc5y1Xu-0xvWyN1rlPoLs9kT3vwxuJVq_EQjmayGIZoUXNwrBf12bmETvojJdJwfj11FgjhFCVYOmYs__Qq_8Ogx5VhNVVayBBP2hWpk7cIP1ubCaRMVZtgTiDeM8Uyf_oPIz3bTyg7Eux_cSXu4lZCaZ76mV6xjF_NPH_2cXl_ss3rEq-BiDsbfDQ1BM1hc764tsfbG1vpiG9uzu2G9Tfnud_AK8bf6_</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925587031</pqid></control><display><type>article</type><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content (ProQuest)</source><creator>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</creator><creatorcontrib>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</creatorcontrib><description>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020. A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases. In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-024-09034-4</identifier><identifier>PMID: 38297224</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Age ; Biomarkers ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 vaccines ; Data collection ; Development and progression ; Disease transmission ; Earthquakes ; Emergency medical care ; Epidemics ; Epidemiology ; Ethics ; Evaluation ; First aid ; First aid in illness and injury ; Forecasts and trends ; Health care ; Health care reform ; Hospital patients ; Hospitals ; Humans ; Hypoxia ; Infection ; Intensive care ; Italy ; Italy - epidemiology ; Kinases ; Laboratories ; Oxygen content ; Oxygen saturation ; Pandemics ; Patient outcomes ; Patients ; Prognosis ; Public health ; Retrospective Studies ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Software ; Survival ; Viral diseases</subject><ispartof>BMC infectious diseases, 2024-01, Vol.24 (1), p.151-12, Article 151</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10829314/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2925587031?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38297224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donida, Bianca Maria</creatorcontrib><creatorcontrib>Pirola, Flavia Simonetta</creatorcontrib><creatorcontrib>Opizzi, Roberto</creatorcontrib><creatorcontrib>Assembergs, Peter</creatorcontrib><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><title>BMC infectious diseases</title><addtitle>BMC Infect Dis</addtitle><description>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020. A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases. In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</description><subject>Age</subject><subject>Biomarkers</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 vaccines</subject><subject>Data collection</subject><subject>Development and progression</subject><subject>Disease transmission</subject><subject>Earthquakes</subject><subject>Emergency medical care</subject><subject>Epidemics</subject><subject>Epidemiology</subject><subject>Ethics</subject><subject>Evaluation</subject><subject>First aid</subject><subject>First aid in illness and injury</subject><subject>Forecasts and trends</subject><subject>Health care</subject><subject>Health care reform</subject><subject>Hospital patients</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Infection</subject><subject>Intensive care</subject><subject>Italy</subject><subject>Italy - epidemiology</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Oxygen content</subject><subject>Oxygen saturation</subject><subject>Pandemics</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Public health</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Software</subject><subject>Survival</subject><subject>Viral diseases</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkttu1DAQhiMEoqXwAlwgS9yA1BSfkti9QWWhsFKllTj01vL6kHWVxMH2LpSH4VlxdkvpIi5QFNmefPNPZvwXxVMETxBi9auIMGt4CTEtIYeElvRecYhog0pMCL1_Z39QPIrxCkLUMMwfFgckLw3G9LD4ee5CTGC2uJy_LREH3-TGADeAtDJgDH7jBmWAt-CNCa3s_TGYJ9ldnwIzOm165zvfOiU7IAcNVOeG7UGtZJAqmeBicioeA79OyvdmS_VykK3pzZAm3amO3f7CysfRZXH3w2gwyuQyER8XD6zsonlysx4VX87ffZ59KC8W7-ezs4tSVYykUslKVtxqYlWlamKXsmqwVbpmhlptl_mtK8qMoZohw5YYk1opgnIGVhQxclTMd7rayysxBtfLcC28dGIb8KEVMuReOiM4k5ZZjSG0Na1QldUgYVLzuqFYc5y1Xu-0xvWyN1rlPoLs9kT3vwxuJVq_EQjmayGIZoUXNwrBf12bmETvojJdJwfj11FgjhFCVYOmYs__Qq_8Ogx5VhNVVayBBP2hWpk7cIP1ubCaRMVZtgTiDeM8Uyf_oPIz3bTyg7Eux_cSXu4lZCaZ76mV6xjF_NPH_2cXl_ss3rEq-BiDsbfDQ1BM1hc764tsfbG1vpiG9uzu2G9Tfnud_AK8bf6_</recordid><startdate>20240131</startdate><enddate>20240131</enddate><creator>Donida, Bianca Maria</creator><creator>Pirola, Flavia Simonetta</creator><creator>Opizzi, Roberto</creator><creator>Assembergs, Peter</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240131</creationdate><title>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</title><author>Donida, Bianca Maria ; Pirola, Flavia Simonetta ; Opizzi, Roberto ; Assembergs, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Biomarkers</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 vaccines</topic><topic>Data collection</topic><topic>Development and progression</topic><topic>Disease transmission</topic><topic>Earthquakes</topic><topic>Emergency medical care</topic><topic>Epidemics</topic><topic>Epidemiology</topic><topic>Ethics</topic><topic>Evaluation</topic><topic>First aid</topic><topic>First aid in illness and injury</topic><topic>Forecasts and trends</topic><topic>Health care</topic><topic>Health care reform</topic><topic>Hospital patients</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Infection</topic><topic>Intensive care</topic><topic>Italy</topic><topic>Italy - epidemiology</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Oxygen content</topic><topic>Oxygen saturation</topic><topic>Pandemics</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Public health</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Software</topic><topic>Survival</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donida, Bianca Maria</creatorcontrib><creatorcontrib>Pirola, Flavia Simonetta</creatorcontrib><creatorcontrib>Opizzi, Roberto</creatorcontrib><creatorcontrib>Assembergs, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Opposing Viewpoints (Gale)</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donida, Bianca Maria</au><au>Pirola, Flavia Simonetta</au><au>Opizzi, Roberto</au><au>Assembergs, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients</atitle><jtitle>BMC infectious diseases</jtitle><addtitle>BMC Infect Dis</addtitle><date>2024-01-31</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>151</spage><epage>12</epage><pages>151-12</pages><artnum>151</artnum><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>Northern Italy was the first European country affected by the spread of the SARS-CoV-2, with the epicenter in the province of Bergamo. This study aims to analyze the characteristics of patients who experienced more severe symptoms during the first wave of COVID-19 pandemic. We retrospectively collected epidemiological and clinical data on patients with laboratory-confirmed wild-type SARS-CoV-2 infection who were admitted to the "ASST Bergamo Ovest" hospital between February 21 and May 31, 2020. A total of seven hundred twenty-three inpatients met the eligible criteria and were included in the study cohort. Among the inpatients who survived, the average hospital length of stay was more than two weeks, with some lasting up to three months. Among the 281 non-survivors, death occurred in 50% within five days. Survivors were those whose first aid operators recorded higher oxygen saturation levels at home. The request for first aid assistance came more than one week after symptom onset, within three days in 10% of cases. In similar future scenarios, based on our data, if we aim to enhance the survival rate, we need to improve the territorial healthcare assistance and admit to hospitals only those patients who are at risk of severe illness requiring specialized and urgent interventions within two, three, or, at most, five days from the onset of symptoms. This implies that the crucial factor is, has been, and will be the ability of a healthcare system to react promptly in its entirety within a few days.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>38297224</pmid><doi>10.1186/s12879-024-09034-4</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2024-01, Vol.24 (1), p.151-12, Article 151
issn 1471-2334
1471-2334
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_98af8fd200f645158b2038ad96742d92
source NCBI_PubMed Central(免费); Publicly Available Content (ProQuest)
subjects Age
Biomarkers
COVID-19
COVID-19 - epidemiology
COVID-19 vaccines
Data collection
Development and progression
Disease transmission
Earthquakes
Emergency medical care
Epidemics
Epidemiology
Ethics
Evaluation
First aid
First aid in illness and injury
Forecasts and trends
Health care
Health care reform
Hospital patients
Hospitals
Humans
Hypoxia
Infection
Intensive care
Italy
Italy - epidemiology
Kinases
Laboratories
Oxygen content
Oxygen saturation
Pandemics
Patient outcomes
Patients
Prognosis
Public health
Retrospective Studies
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Software
Survival
Viral diseases
title First COVID-19 wave in the province of Bergamo, Italy: epidemiological and clinical characteristics, outcome and management of the first hospitalized patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A11%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20COVID-19%20wave%20in%20the%20province%20of%20Bergamo,%20Italy:%20epidemiological%20and%20clinical%20characteristics,%20outcome%20and%20management%20of%20the%20first%20hospitalized%20patients&rft.jtitle=BMC%20infectious%20diseases&rft.au=Donida,%20Bianca%20Maria&rft.date=2024-01-31&rft.volume=24&rft.issue=1&rft.spage=151&rft.epage=12&rft.pages=151-12&rft.artnum=151&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-024-09034-4&rft_dat=%3Cgale_doaj_%3EA782197899%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c583t-ca5a59fd3fc5c63fba572fcd68e4fdfbfdf6548ee4d81e8b2236cc31fd32c4183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2925587031&rft_id=info:pmid/38297224&rft_galeid=A782197899&rfr_iscdi=true